Cp. Miller et al., INHIBITION OF INSULIN PRODUCTION BY CYPROHEPTADINE IN RINM5F RAT INSULINOMA CELLS, Journal of biochemical toxicology, 8(3), 1993, pp. 127-134
The clonal insulin producing cell line RINm5F was evaluated as a model
for the action of cyproheptadine (CPH)-like diabetogenic compounds in
the rat pancreas. Treatment with 10 muM CPH and selected structural a
nalogs under culture conditions produced a progressive loss of cellula
r insulin which reached 30% of control within 24 hours. Comparison of
the activities of the analogs 4-diphenylmethylpiperidine (4-DPMP) and
2-diphenylmethylpiperidine (2-DPMP) to produce cellular insulin deplet
ion showed that 4-DPMP was as active as CPH but 2-DPMP had no activity
at the highest concentration employed (10 muM). The CPH metabolite de
smethyl CPH-epoxide was five times more active than the parent compoun
d in producing loss of insulin in RINm5F cells. These results are cons
istent with previously published results of CPH actions in vivo. An in
hibition of insulin biosynthesis with no loss of preproinsulin mRNA oc
curred in RINm5F cells treated with CPH or DMCPH-epoxide. This suggest
s that an effect on transcription may not be the primary action by whi
ch CPH and its analogs inhibit insulin synthesis in vivo.